CGEM Shares Jump 2.03% on Biotech Rally After Cancer Milestone
CGEM•CGEM shares climbed 2.03% on July 2 as biotech peers rallied following Veraxa’s lead cancer candidate reaching an advanced development milestone. The uptick occurred alongside VRXA’s 18.26% surge, JANX’s 6.00% gain and MGNX’s 1.95% rise, reflecting heightened investor interest in oncology programs.
1. Sector Rally Helps CGEM Shares
On July 2, CGEM shares gained 2.03% amid a broader biotech upturn driven by Veraxa’s lead cancer candidate advancing to a key development milestone. The sector rally saw VRXA jump 18.26%, JANX rise 6.00% and MGNX increase by 1.95%, underscoring renewed investor focus on oncology pipelines.
